Vimta Labs Profit & Loss Annual

BSE: 524394 | NSE: VIMTALABS | ISIN: INE579C01029 | Sector: Biotechnology & Drugs

653.90 +11.60 (1.81%)Updated : 07 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	311.00	257.32	227.70	253.99
Other Net	2.16	1.52	1.23	2.72
Diluted Weighted Average Shares	4.51	4.51	4.50	4.51
Gain( Loss)on Saleof Assets	-0.16	0.03	0.57	0.24
Depreciation/ Amortization	43.77	35.29	33.14	30.71
Total Extraordinary Items	0.00	0.59	-7.80	-
Operating Income	96.69	86.85	60.90	64.20
Net Income	77.51	67.34	41.01	48.17
Income Availableto Com Excl Extra Ord	77.51	66.76	48.81	48.17
Other Operating Expenses Total	1.24	1.43	1.22	0.29
Net Income Before Taxes	103.95	89.00	62.50	65.00
Net Income After Taxes	77.51	66.76	48.81	48.17
Income Availableto Com Incl Extra Ord	77.51	67.34	41.01	48.17
Costof Revenue Total	80.79	71.45	57.66	73.85
Gross Profit	326.90	272.72	230.94	244.34
Interest Inc( Exp) Net- Non- Op Total	5.26	0.61	-0.19	-2.16
Unusual Expense( Income)	1.62	0.00	0.00	0.00
Diluted Net Income	77.51	67.34	41.01	48.17
DPS- Common Stock Primary Issue	2.00	2.00	2.00	1.00
Provisionfor Income Taxes	26.44	22.24	13.69	16.83
period Type	-	-	-	-
Net Income Before Extra Items	77.51	66.76	48.81	48.17
Total Revenue	407.69	344.17	288.59	318.19
period Length	12.00	12.00	12.00	12.00
Revenue	407.69	344.17	288.59	318.19
Selling/ General/ Admin Expenses Total	183.58	149.16	135.68	149.14
Diluted Normalized EPS	17.49	14.79	10.76	10.64
Diluted EPS Excluding Extra Ord Items	17.20	14.80	10.86	10.68

*All figures in crores except per share values

Trending Stocks

2,427.00+57.00(2.41%)

1,653.95+18.95(1.16%)

3,443.60+28.60(0.84%)

1,093.40-56.50 (-4.91%)

2,007.00-82.25 (-3.94%)

Related News